Possibilities of symptomatic treatment of allergic rhinitis in children
https://doi.org/10.21518/2079-701X-2019-17-179-185
Abstract
This article presents an overview of current views on the problem of allergic rhinitis in children. Modern data on the epidemiology of allergic rhinitis and basic comorbid conditions are covered. The issue of patient routing with suspicion of allergic rhinitis and the main directions in the treatment of this disease is briefly discussed. On the basis of the data of the latest consensus papers, the role of various medication therapy for allergic rhinitis has been evaluated: first and second generation antihistamines, intranasal glucocorticosteroids, leukotriene receptor antagonists, and mast cell membrane stabilizers. Possibilities of symptomatic nasal obstruction therapy in case of allergic rhinitis with the help of nasal vasoconstrictor drugs (decongestants) have been assessed in more detail. The basics of pharmacokinetics and pharmacodynamics of decongestants are presented, as well as the data of a clinical study demonstrating the efficacy and safety of the combined preparation of phenylephrine and dimethindene maleate in the symptomatic treatment of allergic rhinitis in children. On the basis of the presented material it is concluded that timely diagnosis and further management of patients with allergic rhinitis in accordance with the principles reflected in modern clinical guidelines, in most cases, allow to effectively control the course of the disease, maintaining the quality of life of patients at a high level.
About the Authors
D. A. Tulupov
Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Denis A. Tulupov, Cand. of Sci. (Med), Associate Professor of the Department of Children’s Otorhinolaryngology
2/1, b. 1, Barrikadnaya St., Moscow, 125993
Е. Р. Karpova
Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Elena P. Karpova, Dr. of Sci. (Med), Professor, Head of the Department of Children’s Otorhinolaryngology
2/1, b. 1, Barrikadnaya St., Moscow, 125993
References
1. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., Zuberbier T., BaenaCagnani C.E., Canonica G.W., van Weel C., Agache I., Ait-Khaled N., Bachert C., Blaiss M.S., Bonini S., Boulet L.P., Bousquet P.J., Camargos P., Carlsen K.H., Chen Y., Custovic A., Dahl R., Demoly P., Douagui H., Durham S.R., van Wijk R.G., Kalayci O., Kaliner M.A., Kim Y.Y., Kowalski M.L., Kuna P., Le L.T., Lemiere C., Li J., Lockey R.F., MavaleManuel S., Meltzer E.O., Mohammad Y., Mullol J., Naclerio R., O’Hehir R.E., Ohta K., Ouedraogo S., Palkonen S., Papadopoulos N., Passalacqua G., Pawankar R., Popov T.A., Rabe K.F., Rosado-Pinto J., Scadding G.K., Simons F.E., Toskala E., Valovirta E., van Cauwenberge P., Wang D.Y., Wickman M., Yawn B.P., Yorgancioglu A., Yusuf O.M., Zar H., Annesi-Maesano I., Bateman E.D., Ben Kheder A., Boakye D.A., Bouchard J., Burney P., Busse W.W., Chan-Yeung M., Chavannes N.H., Chuchalin A., Dolen W.K., Emuzyte R., Grouse L., Humbert M., Jackson C., Johnston S.L., Keith P.K., Kemp J.P., Klossek J.M., Larenas-Linnemann D., Lipworth B., Malo J.L., Marshall G.D., Naspitz C., Nekam K., Niggemann B., Nizankowska-Mogilnicka E., Okamoto Y., Orru M.P., Potter P., Price D., Stoloff S.W., Vandenplas O., Viegi G., Williams D. World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63(86):8–160. doi: 10.1111/j.1398-9995.2007.01620.x.
2. Baranov A.A., Namazova-Baranova L.S., KHaitov R.M., Il’ina N.I., Kurbacheva O.M., Novik G.A., Petrovskiy F.I., Vishneva E.A., Selimzyanova L.R., Alekseyeva A.A. Allergic rhinitis in children. Clinical recommendations. 2016. (In Russ.) Available at: http://www.pediatr-russia.ru/sites/default/files/file/kr_ar.pdf.
3. Canonica G.W., Passalacqua G., Baiardini I., Senna G. Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis. Clin Exp Allergy. 2013;43(1):22-28. doi: 10.1111/j.1365-2222.2012.04052.x.
4. Fokkens W., Lund V., Mullol J., Bachert C., Alobid I., Baroody F., Cohen N., Cervin A., Douglas R., Gevaert P., Georgalas C., Goossens H., Harvey R., Hellings P., Hopkins C., Jones N., Joos G., Kalogjera L., Kern B., Kowalski M., Price D., Riechelmann H., Schlosser R., Senior B., Thomas M., Toskala E., Voegels R., Wang de Y., Wormald P.J. European position paper on rhinosinusitis and nasal polyps 2012 (EP3OS). Rhinology. 2012;50(23):1-299. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22764607.
5. Caffarelli C., Savini E., Giordano S., Gianlupi G., Cavagni G. Atopy in children with otitis media with effusion. Clin Exp Allergy. 1998;28(5):591596. doi: 10.1046/j.1365-2222.1998.00284.x.
6. Canonica G.W., Bousquet J., Mullol J., Scadding G.K., Virchow J.C. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(85):17-25. doi: 10.1111/j.1398-9995.2007.01549.x.
7. Aberg N., Sundell J., Eriksson B., Hesselmar B., Aberg B. Prevalence of allergic diseases in school children in relation to family history, upper respiratory infections, and residential characteristics. Allergy. 1996;51(4):232–237. doi: 10.1111/j.1398-9995.1996.tb04598.x.
8. Tran N.P., Vickery J., Blaiss M.S. Management of Rhinitis: Allergic and Non-Allergic. Allergy Asthma Immunol Res. 2011;3(3):148-156. doi: 10.4168/aair.2011.3.3.148.
9. Roberts G., Xatzipsalti M., Borrego L.M., Custovic A., Halken S., Hellings P.W., Papadopoulos N.G., Rotiroti G., Scadding G., Timmermans F., Valovirta E. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102-1116. doi: 10.1111/all.12235.
10. Marchisio P., Varricchio A., Baggi E., Bianchini S., Capasso M.E., Torretta S., Capaccio P., Gasparini C., Patria F., Esposito S., Principi N. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. Int J Immunopathol Pharmacol. 2012;25(3):721-730. doi: 10.1177/039463201202500318.
11. Abelevich M.M., Abdrakhmanova S.T., Astaf’yeva N.G., Vavilova V.P., Garashchenko T.I., Geppe N.A., Daykhes N.A., Zaytseva O.V., Elkina T.N., ZHernosek V.F., Ivanova N.A., Ispayeva ZH.B., Kamayev A.V., Karneyeyeva O.V., Karpova E.P., Kozlova L.V., Kolosova N.G., Kondyurina E.G., Korostovtsev D.S., Lopatin A.S., Luss L.V., Makarova I.V., Malanicheva T.G., Malakhov A.B., Mash•chkova N.G., Pavlova K.S., Polyakov D.P., Prodeus A.P., Revyakina V.A., Ryazantsev S.V., Sentsova T.B., Svistushkin V.M., Skuchalina L.N., Soldatskiy YU.L., Tarasova G.D., Trishina S.V., Fayzullina R.M., CHepurnaya M.M. RADAR. Recommendations and algorithm at children’s allergic rhinitis. Scientific and practical programme. 2017. (In Russ.) Available at: https://www.google.ru/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=2ahUKEwjus9fAyaDkAhVnpYsKHdYJCBgQFjACegQIAxAB&url=http%3A%2F%2Fmosgorzdrav.ru%2Fru-RU%2Fscience%2Fdefault%2Fdownload%2F100.html&usg=AOvVaw3bRbJqbNPxPuZNGkPeNDgL.
12. Brozek J.L., Bousquet J., Baena-Cagnani C.E., Bonini S., Canonica G.W., Casale T.B., van Wijk R.G., Ohta K., Zuberbier T., Schunemann H.J.; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466476. doi: 10.1016/j.jaci.2010.06.047.
13. Revyakina V.A. Antihistamines in clinical practice. Discussion questions. Doctor’s view on usual medications. Lechashchiy vrach = Attending physician. 2010;(7):71-73.] (In Russ.) Available at: https://www.lvrach.ru/2010/07/15081966/.
14. Church M.K., Maurer M. Antihistamines. Chem Immunol Allergy. 2014;(100):302-10. doi: 10.1159/000359963
15. Gonzalez M.A., Estes K.S. Pharmacokinetic overview of oral second-generation H1 antihistamines. Int J Clin Pharmacol Ther. 1998; 36(5):292-300. Available at: https://www.ncbi.nlm.nih.gov/pubmed/9629995.
16. Ten Eick A.P., Blumer J.L., Reed M.D. Safety of antihistamines in children. Drug Saf. 2001;24(2):119-147. doi: 10.2165/00002018200124020-00003.
17. Sastre J., Mosges R. Local and Systemic Safety of Intranasal Corticosteroids. J Investig Allergol Clin Immunol. 2012;22(1):1-12. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22448448.
18. Wolthers O.D. Relevance of pharmacokinetics and bioavailability of intranasal corticosteroids in allergic rhinitis. Recent Pat Inflamm Allergy Drug Discov. 2010;4(2):118-123. Available at: https://www.ncbi.nlm.nih.gov/pubmed/20001898.
19. Karpova E.P., Vorob’yeva M.P., Tulupov D.A. Possibilities of application of decongestants at children. Pediatriya. Prilozheniye k zhurnalu Consilium Medicum = Pediatrics. Appendix to the journal Consilium Medicum. 2018;(1):43-45. (In Russ.)
20. Available at: https://con-med.ru/magazines/pediatry/pediatry-01-2018/vozmozhnosti_primeneniya_dekongestantov_u_detey/.
Review
For citations:
Tulupov DA, Karpova ЕР. Possibilities of symptomatic treatment of allergic rhinitis in children. Meditsinskiy sovet = Medical Council. 2019;(17):179-185. (In Russ.) https://doi.org/10.21518/2079-701X-2019-17-179-185
Views:
800
Email this article 